- Home
- ZOM vs DHF Comparison
ZOM vs DHF Comparison
Compare ZOM & DHF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZOM
- DHF
- Stock Information
- Founded
- ZOM 2015
- DHF 1998
- Country
- ZOM United States
- DHF United States
- Employees
- ZOM N/A
- DHF N/A
- Industry
- ZOM Biotechnology: Pharmaceutical Preparations
- DHF Finance Companies
- Sector
- ZOM Health Care
- DHF Finance
- Exchange
- ZOM Nasdaq
- DHF Nasdaq
- Market Cap
- ZOM 135.9M
- DHF 191.3M
- IPO Year
- ZOM N/A
- DHF N/A
- Fundamental
- Price
- ZOM $0.12
- DHF $2.60
- Analyst Decision
- ZOM
- DHF
- Analyst Count
- ZOM 0
- DHF 0
- Target Price
- ZOM N/A
- DHF N/A
- AVG Volume (30 Days)
- ZOM 3.1M
- DHF 451.1K
- Earning Date
- ZOM 11-11-2024
- DHF 01-01-0001
- Dividend Yield
- ZOM N/A
- DHF 7.65%
- EPS Growth
- ZOM N/A
- DHF N/A
- EPS
- ZOM N/A
- DHF N/A
- Revenue
- ZOM $26,077,000.00
- DHF N/A
- Revenue This Year
- ZOM $36.75
- DHF N/A
- Revenue Next Year
- ZOM $14.92
- DHF N/A
- P/E Ratio
- ZOM N/A
- DHF N/A
- Revenue Growth
- ZOM 16.23
- DHF N/A
- 52 Week Low
- ZOM $0.12
- DHF $2.06
- 52 Week High
- ZOM $0.23
- DHF $2.39
- Technical
- Relative Strength Index (RSI)
- ZOM 42.09
- DHF 48.99
- Support Level
- ZOM $0.13
- DHF $2.60
- Resistance Level
- ZOM $0.13
- DHF $2.65
- Average True Range (ATR)
- ZOM 0.00
- DHF 0.04
- MACD
- ZOM -0.00
- DHF -0.01
- Stochastic Oscillator
- ZOM 2.86
- DHF 5.00
About ZOM Zomedica Corp.
Zomedica Corp is a veterinary health company creating products for companion animals (canine, feline and equine) by focusing on the unmet needs of clinical veterinarians. The company's product portfolio includes diagnostics and therapeutics that emphasize patient health and practice health. The company is focused on the final development and commercialization of its TRUFORMA platform, which detects thyroid disorders in dogs & cats and adrenal disorders in dogs. Its operations are comprised of two reportable segments namely Diagnostic and Therapeutic Devices. It earns the majority of revenue from the therapeutics segment.
About DHF BNY Mellon High Yield Strategies Fund
BNY Mellon High Yield Strategies Fund is a diversified, closed-end management investment company. The fund's primary investment objective is to seek high current income and its secondary objective is capital appreciation. It invests predominantly in fixed-income securities of below-investment-grade credit quality.